Paused studies of leading Covid-19 vaccine candidates from AstraZeneca PLC and Johnson & Johnson are resuming, the companies said Friday.
The restarts mean testing of two of the most advanced Covid-19 vaccines in development can get back on track after their testing had been sidetracked. The testing is crucial for regulators to evaluate whether the vaccines safely protect against the virus and should be given widely.
The…
